- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02088853
Diet Induced Intestinal Mucosal Adaptation
June 30, 2025 updated by: Göteborg University
Small Intestinal Adaptation to Isocaloric Diets Dominated Either by Fats or Carbohydrates
Human beings are 'omnivores' meaning that all principal components of food (i.e. the macronutrients: carbohydrates, fat, proteins) can be assimilated by the gastrointestinal tract.
When the gut mucosa is exposed to dietary changes it adjusts its functional behaviour.
For example, a fatty diet demands certain digestive mechanisms, whereas others are needed to take care of a carbohydrate rich diet.
Such dietary induced changes in appearance and functionality of the small intestinal mucosa have been described in animals but only little is known about it in man.
The present project aims at elucidating in man if a 2 weeks diet dominated by either fat or carbohydrates, but with similar energy content, is associated with changes in the small intestinal mucosal appearance and metabolic signalling capacity.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
17
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Gothenburg, Sweden, SE41345
- Dept of Gastrosurgical R&E, Sahlgrenska Universityhospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
healthy volunteer not taking prescribed medications BMI ≤25 kg/m2
Exclusion Criteria:
BMI ≥26 kg/m2 smoker previous or current gastrointestinal disease significant abdominal surgery pregnancy/breast feeding drug intolerance of importance (particularly opiates and midazolam used during endoscopy) history of drug addiction
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: First high fat diet, then high carbohydrate diet
had; first sixty percent fat as the energy source, then sixty percent carbohydrates
|
Sixty % of the energy content is based on fat, then sixty % of the energy content is based on carbohydrates
|
|
Experimental: First, high carb diet, then high fat diet
had; first sixty percent carbohydrates as the energy source, the sixty percent fat
|
Sixty % of the energy content is based on carbohydrates, then sixty % of the energy content is based on fat
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mucosal Surface Enlargement
Time Frame: Appearance after 2 weeks of each diet
|
The enlargement of the luminal surface area is a morphometric factor, defined as the percentage of the mucosal surface (one dimension in arbitrary units) in relation to the relatively flat area of the muscular mucosae layer from the same histological cuts.
Unit: % of the muscular mucosae.
|
Appearance after 2 weeks of each diet
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glucose Induced Electrogenic Responses In-vitro
Time Frame: The condition after 2 weeks of each diet
|
Jejunal mucosal biopsies are mounted as a sheet between two different (glucose-free) physiological solutions (in so called Ussing chambers).
The electrogenic response to glucose will be measured as follows: Baseline ion-transporting capacity for the luminal to serosa side will be measured as the epithelial current (Iep) in the absence of glucose (unit; µA/cm2).
Addition of 10mM glucose on the luminal side increases the ion-transporting capacity.
This level will be divided with preceding baseline ion-transporting capacity and is presented as % change from the baseline secretion.
The sensitivity of this response to phloridzin is given to confirm to what extent the glucose transporter SGLT1 is involved.
Only the completed pairs (high fat diet versus high carbohydrate diet) will be analyzed.
|
The condition after 2 weeks of each diet
|
|
Glycemic Control Following a Test Meal
Time Frame: The condition after 2 weeks of each diet
|
Blood concentrations of glucose are assessed over 2 hours following a mixed test meal.
|
The condition after 2 weeks of each diet
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Lars Fändriks, MD, PhD, Göteborg University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2014
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
March 13, 2014
First Submitted That Met QC Criteria
March 14, 2014
First Posted (Estimated)
March 17, 2014
Study Record Updates
Last Update Posted (Actual)
July 17, 2025
Last Update Submitted That Met QC Criteria
June 30, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- BUTTER
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.